Volume: 43 Issue: Supplementary 1
Year: 2023, Page: 230-235, Doi: https://doi.org/10.51248/.v43i1.2413
Introduction and Aim: Due to the Coronavirus outbreaks, the SARS-CoV-2, also known as COVID-19, has claimed several lives around the world, with the majority of them being elderly, suffering from underlying chronic illnesses, or living in vulnerable conditions. This study aimed to find the immunological factors CD-79, CD-4, IL-2, and TNF-B in COVID-19 patients utilizing nucleocapsid-(N), a protein structure that interacts with genomic RNA to create complexes.
Materials and Methods: SARS-COV-2 infection was detected using RT-PCR. The serum levels of IL-2 and TNF-B, as well as the concentrations of CD4 and CD79, were measured. This study included 100 COVID-19 patients.
Results: The results showed that the serum concentration of TNF-β and IL-2 in COVID19 patients was significantly higher than that in the general population (with acute and moderate illness) when compared to normal control groups (p<0.05). COVID-19 patients reported higher levels of CD79 as well as CD4 expression than healthy control groups in a study of activated markers.
Conclusion: Infection with SARS-COV-2 has a high impact on various immunological and inflammatory markers in patients.
Keywords: Covid-19; nucleocapsids gene (N); RT-PCR; inflammatory factors
1. Weiss, S.R., Leibowitz, J.L. Coronavirus pathogenesis. Adv. Virus Res. 2011; 81: 85-164.
2. Ismael, M.K., Rasuol, L.M. and Qaddoori, Y.B. Investigation of the relationship between matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 with SARS CoV-2 infections. Adv Biotechnol Exp Ther. 2023;6(1): 35-43.
3. Yang, Y., Peng, F., Wang, R., Guan, K., Jiang, T., Xu, G., et al., The deadly coronaviruses: The 2003 SARS pandemic and the 2020 novel coronavirus epidemic in China. J Autoimmun. 2020; 109: 102487.
4. Fehr, A.R., Perlman, S. Coronaviruses: an overview of their replication and pathogenesis. Methods Mol. Biol. 2015; 1282 :1-23.
5. Ismael, M.K., Aldabagh, M.A., Rasuol, L.M. Matrix metalloproteinase-3 and tissue inhibitor of metalloproteinase-2 as Diagnostic markers for COVID-19 Infection. Iraqi Journal of Science. 2022; 63(9): 3679-3687.
6. Liu, J., Wu, P., Gao, F., Qi, J., Kawana-Tachikawa, A., Xie, J., et al., Novel immunodominant peptide presentation strategy: a featured HLA-A*2402-restricted cytotoxic T-lymphocyte epitope stabilized by intrachain hydrogen bonds from severe acute respiratory syndrome coronavirus nucleocapsid protein, J. Virol.2010; 84 (22):11849e11857.
7. Ahmadpoor, P., Rostaing, L. Why the immune system fails to mount an adaptive immune response to a Covid -19 infection. Transpl. Int. 2020; 33 (7):824-825.
8. Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., et al., Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020; 395 (10223): 497-506.
9. Al-Rubii, B.A.L. Cloning LasB gene of Pseudomonas aeruginosa elastase 10104-2aI in E. coli BL21 and E. coli DH5α and investigated their effect on the stripping of Vero cells. Pakistan J. Biotechnol. 2017; 14(4):697-705.
10. Abdulrazaq, R.A., Mahmood, W.S., Alwan, B., Saleh, T.H., Hashim, S.T., Al-Rubaii, B.A.L. Biological study of protease produced by clinical isolates of Staphylococcus aureus. Res J Pharm Technol.2022; 15(12):5415-5420.
11. Melchjorsen, J., Sørensen, L.N., Paludan, S.R. Expression, and function of chemokines during viral infections: from molecular mechanisms to in vivo function. J Leukoc Biol. 2003; 74(3):331-343.
12. Alcami, A. Viral mimicry of cytokines, chemokines, and their receptors. Nat Rev Immunol. 2003;3(1):36-50.
13. Mahalingam, S., Friedland, J.S., Heise, M.T., Rulli, N.E., Meanger, J., Lidbury, B.A. Chemokines and viruses: friends or foes? Trends Microbiol. 2003; 11(8):383-391.
14. Maghazachi, A.A., Al-Aoukaty, A., Schall, T.J. CC chemokines induce the generation of killer cells from CD56+ cells. Eur J Immunol. 1996; 26(2):315-319.
15. Tu, X., Chong, W.P., Zhai, Y., Zhang, H., Zhang, F., Wang, S., et al., Functional polymorphisms of the CCL2 and MBL
genes cumulatively increase susceptibility to severe acute respiratory syndrome coronavirus infection, J Infect. 2015; 71(1): 101-109.
16. Rasoul, L.M., Nsaif, M.M., Al-Tameemi, M.T., Al-Rubaii, B.A.L. Estimation of primer efficiency in multiplex PCR for detecting SARS-Cov-2 variants. Bionatura, 2022, 7(3): doi.org/10.21931/RB/2022.07.49.
17. Fan, Y.Y., Huang, Z.T., Li, L., Wu, M.H., Yu, T., Koup, R.A., et al., Characterization of SARS-CoV-specific memory T cells from recovered individuals 4 years after infection, Arch. Virol. 2009; 154 (7): 1093-1099.
18. Tang, F., Quan, Y., Xin, Z.T., Wrammert, J., Ma, M.J., Lv, H., et al., Lack of peripheral memory B cell responses in recovered patients with severe acute respiratory syndrome: a six-year follow up Follow-up study, J. Immunol. 2011; 186 (12):7264-7268.
19. Zhao, J., Li, K., Wohlford-Lenane, C., Agnihothram, S.S., Fett, C., Zhao, J., et al., Rapid generation of a mouse model for Middle East respiratory syndrome, Proc. Natl. Acad. Sci. 2014; 111(3):4970-4975.
20. Williams, A.E., Chambers, R.C. The mercurial nature of neutrophils: still an enigma in ARDS? Am. J. Physiol. Lung Cell Mol. Physiol.2014; 306 (3): 217-230.
21. Channappanavar, R., Perlman, S. Pathogenic human coronavirus infections, causes and consequences of cytokine storm and immunopathology, Semin. Immunopathol. 2017; 39(5):529-539.
22. Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., Cao, B. (2020). Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. The lancet, 395(10223), 497-506.
Mohammed S. Abbas, Ahmed Ghaith Ahmed, Sura Qusay Ali, Bahaa Abdullah Lafttah AL-Rubaii. Immunological inflammatory factors in patients diagnosed with COVID-19. Biomedicine: 2023; 43(1) Supplementary issue: 230-235